• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OPT 0.90% 56.0¢

OPTHEA LIMITED

Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The... Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The Company has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OPT 23/08/24 188 42K
23/08/24 Last post  Tekvest Comments Created with Sketch.  188  Views Created with Sketch.  42K 
OPT
Opthea Q and A
22/08/24 37 6.6K
22/08/24 Last post  willxue123 Comments Created with Sketch.  37  Views Created with Sketch.  6.6K 
OPT
Eyebio vs Opthea
21/08/24 1 373
21/08/24 Last post  primaus72 Comments Created with Sketch.  1  Views Created with Sketch.  373 
OPT 16/08/24 2 1.0K
16/08/24 Last post  Bunter62 Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
OPT
Biosimilar Update
14/08/24 11 2.5K
14/08/24 Last post  primaus72 Comments Created with Sketch.  11  Views Created with Sketch.  2.5K 
OPT 01/08/24 1 892
01/08/24 Last post  FreeFromStyle Comments Created with Sketch.  1  Views Created with Sketch.  892 
OPT 01/08/24 6 2.1K
01/08/24 Last post  whytee Comments Created with Sketch.  6  Views Created with Sketch.  2.1K 
OPT 01/08/24 125 42K
01/08/24 Last post  Allr Comments Created with Sketch.  125  Views Created with Sketch.  42K 

See All Discussions arrow Created with Sketch.

Timeline

Opthea to Participate in H.C Wainwright Virtual Conference
09 Aug 08:16
 
Updated Quarterly Report and Cashflow
01 Aug 16:13
 
Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 10:17
 
Change in substantial holding
19 Jul 17:12
 
Change in substantial holding
19 Jul 08:18
 
Opthea Welcomes Retina Leaders to its Medical Advisory Board
18 Jul 08:23
 
View More arrow Created with Sketch.
(20min delay)
Last
56.0¢
Change
0.005(0.90%)
Mkt cap ! $689.4M
Open High Low Value Volume
55.0¢ 56.5¢ 55.0¢ $1.173M 2.097M

Buyers (Bids)

No. Vol. Price($)
2 30360 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
57.0¢ 35361 3
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
56.0¢
  Change
0.005 ( 1.43 %)
Open High Low Volume
55.3¢ 56.5¢ 55.0¢ 486500
Last updated 15.59pm 23/08/2024 ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.